Legius syndrome
(Redirected from Neurofibromatosis type 1-like syndrome)
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
Legius syndrome | |
---|---|
![]() | |
Synonyms | Neurofibromatosis type 1-like syndrome, NF1-like syndrome |
Pronounce | |
Specialty | Medical genetics |
Symptoms | Café-au-lait spots, freckling, macrocephaly, learning disabilities |
Complications | N/A |
Onset | Childhood |
Duration | Lifelong |
Types | N/A |
Causes | Mutations in the SPRED1 gene |
Risks | |
Diagnosis | Clinical diagnosis, genetic testing |
Differential diagnosis | Neurofibromatosis type I, Noonan syndrome, McCune-Albright syndrome |
Prevention | N/A |
Treatment | Symptomatic treatment, educational support |
Medication | N/A |
Prognosis | Generally good |
Frequency | Rare |
Deaths |
Legius syndrome is a rare genetic disorder that is characterized by multiple café-au-lait spots on the skin, freckling in the armpits and groin, and other features that can resemble neurofibromatosis type I (NF1). It is caused by mutations in the SPRED1 gene.
Signs and Symptoms
Individuals with Legius syndrome typically present with:
- Multiple café-au-lait spots
- Freckling in the armpits and groin
- Macrocephaly (large head size)
- Learning disabilities
- Developmental delays
Unlike neurofibromatosis type I, Legius syndrome does not involve the development of neurofibromas, Lisch nodules (iris hamartomas), or optic gliomas.
Genetics
Legius syndrome is caused by mutations in the SPRED1 gene, which is located on chromosome 15q14. The SPRED1 gene encodes a protein that is involved in the Ras/MAPK signaling pathway, which is important for cell growth and differentiation. Mutations in this gene lead to the clinical features observed in Legius syndrome.
Diagnosis
The diagnosis of Legius syndrome is primarily clinical, based on the presence of characteristic skin findings and the absence of other features of neurofibromatosis type I. Genetic testing can confirm the diagnosis by identifying mutations in the SPRED1 gene.
Management
There is no cure for Legius syndrome, and management is primarily supportive. This may include:
- Regular monitoring of skin lesions
- Educational support for learning disabilities
- Developmental assessments and interventions
Differential Diagnosis
Legius syndrome should be differentiated from other conditions that present with similar features, such as:
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD